Descriptor English: | Lurasidone Hydrochloride | ||||
Descriptor Spanish: |
Clorhidrato de Lurasidona
| ||||
Descriptor Portuguese: | Cloridrato de Lurasidona | ||||
Descriptor French: | Chlorhydrate de lurasidone | ||||
Entry term(s): |
13496, SM HCl, Lurasidone Hydrochloride, Lurasidone Latuda Lurasidone Lurasidone HCl N-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinylmethyl)-1-cyclohexylmethyl)-2,3-bicyclo(2.2.1)heptanedicarboximide SM 13,496 SM 13496 SM-13,496 SM-13496 SM13,496 SM13496 |
||||
Tree number(s): |
D02.886.675.414 D03.383.129.708.414 D03.633.100.513.437 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000069056 | ||||
Scope note: | A thiazole derivative and atypical ANTIPSYCHOTIC AGENT that functions as a DOPAMINE D2 RECEPTOR ANTAGONIST; SEROTONIN 5-HT2 RECEPTOR ANTAGONIST, serotonin 5-HT7 receptor antagonist, and antagonist of the adrenergic α2A and α2C receptors, as well as a partial SEROTONIN 5-HT1A RECEPTOR AGONIST. It is used in the treatment of SCHIZOPHRENIA and BIPOLAR DISORDER. |
||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
Pharm Action: |
Antipsychotic Agents Adrenergic alpha-2 Receptor Antagonists Serotonin 5-HT2 Receptor Antagonists Dopamine D2 Receptor Antagonists |
||||
Registry Number: | O0P4I5851I | ||||
Public MeSH Note: | 2016; LURASIDONE HYDROCHLORIDE was indexed under ISOINDOLES and THIAZOLES 2008-2015 |
||||
History Note: | 2016 (2008) |
||||
DeCS ID: | 55906 | ||||
Unique ID: | D000069056 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 2016/01/01 | ||||
Date of Entry: | 2015/07/09 | ||||
Revision Date: | 2016/05/31 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Lurasidone Hydrochloride
- Preferred
SM 13496
- Narrower
Lurasidone
- Broader
Latuda
- Narrower
Concept UI |
M000604584 |
Scope note | A thiazole derivative and atypical ANTIPSYCHOTIC AGENT that functions as a DOPAMINE D2 RECEPTOR ANTAGONIST; SEROTONIN 5-HT2 RECEPTOR ANTAGONIST, serotonin 5-HT7 receptor antagonist, and antagonist of the adrenergic α2A and α2C receptors, as well as a partial SEROTONIN 5-HT1A RECEPTOR AGONIST. It is used in the treatment of SCHIZOPHRENIA and BIPOLAR DISORDER. |
Preferred term | Lurasidone Hydrochloride |
Entry term(s) |
HCl, Lurasidone Hydrochloride, Lurasidone Lurasidone HCl |
Concept UI |
M0517366 |
Preferred term | SM 13496 |
Entry term(s) |
13496, SM SM 13,496 SM-13,496 SM-13496 SM13,496 SM13496 |
Concept UI |
M0517365 |
Preferred term | Lurasidone |
Entry term(s) |
N-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinylmethyl)-1-cyclohexylmethyl)-2,3-bicyclo(2.2.1)heptanedicarboximide |
Concept UI |
M000604585 |
Preferred term | Latuda |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey